Isolating cognitive and neurologic HIV effects in substance-dependent, confounded cohorts: a pilot study
- PMID: 23446056
- PMCID: PMC3815532
- DOI: 10.1017/S1355617712001634
Isolating cognitive and neurologic HIV effects in substance-dependent, confounded cohorts: a pilot study
Abstract
Controversy exists as to whether effects of HIV infection can be detected in the cognitive profiles of substance users, with methodological differences in degree of control for confounding factors a major contributor to empirical discrepancies. To address this shortcoming, we conducted a small but well-controlled study aimed at isolating HIV neurocognitive (NC) effects in a group of chronic substance users. Thirty HIV-negative substance users were individually matched to 30 HIV-positive substance users on relevant medical and demographic factors, including reading level and methadone therapy status. Results revealed that reading level, methadone maintenance therapy, and positive urine toxicology each exerted significant influence on NC function, and that HIV status was a significant predictor of learning and speeded processing after these control factors were considered. The HIV-positive group also displayed significantly more neurologically assessed motor impairment (p < .05), which was specifically related to impaired cognition in this group and independent of degree of immunocompromise. These data demonstrate the need for increased attention to clinical/demographic characteristics of groups under study. They also show that with applied methodological rigor, the deleterious effects of HIV on cognition can be parsed from substance use, even in small samples with chronic and active use histories.
Conflict of interest statement
The authors report no conflicts of interest.
Similar articles
-
Neurocognitive effects of HIV, hepatitis C, and substance use history.J Int Neuropsychol Soc. 2012 Jan;18(1):68-78. doi: 10.1017/S1355617711001408. Epub 2011 Dec 2. J Int Neuropsychol Soc. 2012. PMID: 22132928 Free PMC article.
-
Relationship of beta 2 microglobulin and CD4 counts to neuropsychological performance in HIV-1-infected intravenous drug users.J Acquir Immune Defic Syndr (1988). 1994 Oct;7(10):1040-9. J Acquir Immune Defic Syndr (1988). 1994. PMID: 7916050
-
Relationship between menopause symptoms and HIV risk among midlife women in methadone treatment: a pilot study.Subst Use Misuse. 2013 Jun;48(9):711-8. doi: 10.3109/10826084.2013.787090. Epub 2013 Apr 22. Subst Use Misuse. 2013. PMID: 23607674
-
Risk factors associated with HIV/HCV infection among entrants in methadone maintenance treatment clinics in China: a systematic review and meta-analysis.Drug Alcohol Depend. 2012 Dec 1;126(3):286-95. doi: 10.1016/j.drugalcdep.2012.05.028. Epub 2012 Jun 20. Drug Alcohol Depend. 2012. PMID: 22726912 Review.
-
Cognitive function in HIV-1-infected drug users.J Acquir Immune Defic Syndr. 2000 Oct 1;25 Suppl 1:S70-3. doi: 10.1097/00042560-200010001-00011. J Acquir Immune Defic Syndr. 2000. PMID: 11126430 Review.
Cited by
-
Neurocognitive intra-individual variability within HIV+ adults with and without current substance use.Neuropsychology. 2020 Mar;34(3):321-330. doi: 10.1037/neu0000612. Epub 2019 Dec 30. Neuropsychology. 2020. PMID: 31886690 Free PMC article.
-
CCR2 on CD14(+)CD16(+) monocytes is a biomarker of HIV-associated neurocognitive disorders.Neurol Neuroimmunol Neuroinflamm. 2014 Oct 9;1(3):e36. doi: 10.1212/NXI.0000000000000036. eCollection 2014 Oct. Neurol Neuroimmunol Neuroinflamm. 2014. PMID: 25340088 Free PMC article.
-
Effects of information processing speed on learning, memory, and executive functioning in people living with HIV/AIDS.J Clin Exp Neuropsychol. 2014;36(8):806-17. doi: 10.1080/13803395.2014.943696. Epub 2014 Aug 11. J Clin Exp Neuropsychol. 2014. PMID: 25111120 Free PMC article.
-
Inter-trial variability in brain activity as an indicator of synergistic effects of HIV-1 and drug abuse.Drug Alcohol Depend. 2018 Oct 1;191:300-308. doi: 10.1016/j.drugalcdep.2018.07.010. Epub 2018 Aug 22. Drug Alcohol Depend. 2018. PMID: 30170301 Free PMC article.
-
Cognitive and socio-cognitive functioning of chronic non-medical prescription opioid users.Psychopharmacology (Berl). 2018 Dec;235(12):3451-3464. doi: 10.1007/s00213-018-5060-z. Epub 2018 Oct 11. Psychopharmacology (Berl). 2018. PMID: 30310961
References
-
- Baldewicz TT, Leserman J, Silva SG, Petitto J, Golden RN, Perkins DO, Evans DL. Changes in neuropsycho-logical functioning with progression of HIV-1 infection: Results of an 8-year longitudinal investigation. AIDS and Behavior. 2004;8(3):345–355. - PubMed
-
- Basso M, Bronstein R. Neurobehavioural consequences of substance abuse and HIV infection. Psychopharmacology. 2000;14(3):228–237. - PubMed
-
- Basso M, Bronstein R. Effects of past noninjection drug abuse upon executive function and working memory in HIV infection. Journal of Clinical and Experimental Neuropsychology. 2003;25(7):893–903. - PubMed
-
- Bell J, Arango J, Anthony I. Neurobiology of multiple insults: HIV-1-associated brain disorders in those who use illicit drugs. Journal of Neuroimmune Pharmacology. 2006;1(2):182–191. - PubMed
-
- Bell JE, Brettle RP, Chiswick AA, Simmonds PP. HIV encephalitis, proviral load and dementia in drug users and homosexuals with AIDS: Effect of neocortical involvement. Brain. 1998;121(11):2043–2052. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical